title: Population pharmacokinetic analysis of the oral thrombin inhibitor dabigatran etexilate in patients with non-valvular atrial fibrillation from the RE-LY trial: a rebuttal.
authors.forename: J P
authors.initials: JP
authors.lastname: Patel
authors.forename: B
authors.initials: B
authors.lastname: Green
authors.forename: R K
authors.initials: RK
authors.lastname: Patel
authors.forename: J G
authors.initials: JG
authors.lastname: Davies
authors.forename: R
authors.initials: R
authors.lastname: Arya
mesh_terms: D001281:Atrial Fibrillation / Q000188:drug therapy*; D001562:Benzimidazoles / Q000493:pharmacokinetics*; D006801:Humans; D011725:Pyridines / Q000493:pharmacokinetics*; D013917:Thrombin / Q000037:antagonists & inhibitors*
chemical_list: D001562:Benzimidazoles; D011725:Pyridines; D013917:Thrombin